secwatch.observer — SEC 8-K summary
======================================

Issuer:     AGIOS PHARMACEUTICALS, INC. (AGIO)
CIK:        0001439222
Form:       8-K
Filed at:   2023-05-25T23:59:59+00:00
Accession:  0001193125-23-154190
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Agios director John Maraganore resigns; Catherine Owen elected to board
-----------------------------------------------------------------------

- John Maraganore resigned from board effective May 24, 2023, after nearly 12 years.
- Kaye Foster appointed lead independent director; Cynthia Smith becomes Compensation & People Committee chair.
- Catherine Owen elected as class II director effective June 13, 2023; joins Compensation & People Committee.
- Owen receives annual cash: $50,000 as director plus $7,500 for committee service.
- Owen granted initial equity: nonstatutory option with $472,500 Black-Scholes value and RSUs valued at $157,500.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1439222/000119312523154190/0001193125-23-154190-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1439222/000119312523154190/d509829d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-154190

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer